Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
83%
Allergic Reaction
20%
Anaphylaxis
20%
Antipsychotic
20%
Bioequivalence
20%
Biosimilar Agent
20%
Camostat
10%
Camostat Mesilate
40%
Cancer Pain
31%
Cannabidiol
50%
Cannabis
61%
Carpal Tunnel Syndrome
20%
Chronic Kidney Failure
20%
Clinical Pharmacokinetics
20%
Clonidine
20%
Controlled Clinical Trial
20%
Coronavirinae
20%
Delirium
20%
Disease
23%
Drug-Drug Interaction
25%
Duragesic
40%
Fatality
20%
Heart Failure
20%
Immunoglobulin E
20%
Infliximab
20%
Lidocaine
10%
Medication Error
82%
Metoprolol
20%
Multiple Sclerosis
39%
Nabiximols
34%
Neuropathic Pain
44%
Normal Human
21%
Opiate
46%
Pharmacodynamics
48%
Pharmacokinetic Parameter
12%
Pharmacokinetics
50%
Pharmacokinetics
20%
Placebo
80%
Polypharmacy
20%
Randomized Controlled Trial
40%
Serine Proteinase
20%
Side Effect
36%
Spasticity
48%
Spinal Cord Injury
31%
Tetrahydrocannabinol
46%
Tolerability
20%
Transdermal Delivery
40%
Tumor Necrosis Factor
20%
Typical Antipsychotic
20%
Verapamil
20%
Medicine and Dentistry
Adverse Event
40%
Antivirus Agent
10%
Biological Therapy
20%
Biosimilar
20%
Camostat Mesilate
20%
Cannabidiol
18%
Cannabis
30%
Carpal Tunnel Syndrome
20%
Clinical Trial
9%
Cohort Analysis
20%
Counseling
37%
COVID-19
22%
Disease
6%
Drug Interaction
25%
Drug Therapy
100%
Effects of Cannabis
22%
Etanercept
8%
Fetus Risk
10%
General Medicine
20%
General Practitioner
9%
Glucocorticoid
10%
Health Care
10%
High Risk Population
16%
Infection
6%
Infliximab
20%
Lidocaine
10%
Local Anesthesia
20%
Local Anesthetic
10%
Medication Error
57%
Medicine
40%
Membrane Fusion
6%
Multiple Sclerosis
31%
Nabiximols
27%
Neuropathic Pain
40%
Patient Population
13%
Pharmacodynamics
6%
Pharmacokinetics
6%
Placebo
40%
Polypharmacy
20%
Quality of Life
7%
Randomized Controlled Trial
20%
Rheumatology
20%
Risk Stratification
22%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Side Effect
10%
Spasticity
40%
Spinal Cord Injury
31%
Systematic Review
20%
Tetrahydrocannabinol
14%
Tumor Necrosis Factor
20%
Keyphrases
Allergy Label
5%
Cancer Pain Management
5%
Chat Generative Pre-trained Transformer (ChatGPT)
20%
ChatGPT-3.5
10%
Clinical Impact
5%
Clinical Interpretation
5%
Clinical Pharmacology
20%
Clinically Significant
5%
Counseling Services
10%
Denmark
5%
Drug Dependence
20%
Histamine Release
5%
IgE-mediated Allergy
5%
Large Language Models
5%
Medical Community
5%
Medication Errors
15%
Medium Resolution Imaging Spectrometer (MERIS)
8%
Multiple Answers
5%
Non-IgE
5%
Patient Notes
5%
Pharmacist Counseling
15%
Prescribing Errors
5%
Retrospective Investigation
5%
Severe Allergic Reactions
5%
